Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein
- PMID: 10571006
- DOI: 10.1016/s0925-4439(99)00075-7
Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein
Abstract
GM1 gangliosidosis and Morquio B disease are distinct disorders both clinically and biochemically yet they arise from the same beta-galactosidase enzyme deficiency. On the other hand, galactosialidosis and sialidosis share common clinical and biochemical features, yet they arise from two separate enzyme deficiencies, namely, protective protein/cathepsin A and neuraminidase, respectively. However distinct, in practice these disorders overlap both clinically and biochemically so that easy discrimination between them is sometimes difficult. The principle reason for this may be found in the fact that these three enzymes form a unique complex in lysosomes that is required for their stability and posttranslational processing. In this review, I focus mainly on the primary and secondary beta-galactosidase deficiency states and offer some hypotheses to account for differences between GM1 gangliosidosis and Morquio B disease.
Similar articles
-
Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology.Prog Nucleic Acid Res Mol Biol. 2001;69:81-114. doi: 10.1016/s0079-6603(01)69045-7. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11550799 Review.
-
Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.Am J Hum Genet. 2000 Jul;67(1):23-36. doi: 10.1086/302968. Epub 2000 Jun 6. Am J Hum Genet. 2000. PMID: 10841810 Free PMC article.
-
Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis).Hum Genet. 1994 Feb;93(2):109-14. doi: 10.1007/BF00210592. Hum Genet. 1994. PMID: 8112731
-
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.Eur J Med Chem. 2017 Jan 27;126:160-170. doi: 10.1016/j.ejmech.2016.09.095. Epub 2016 Sep 29. Eur J Med Chem. 2017. PMID: 27750150
-
[Molecular genetics of beta-galactosidase deficiency (GM1-gangliosidosis and Morquio syndrome type B)].Nihon Rinsho. 1993 Sep;51(9):2269-75. Nihon Rinsho. 1993. PMID: 8411701 Review. Japanese.
Cited by
-
Morquio B patient/caregiver survey: First insight into the natural course of a rare GLB1 related condition.Mol Genet Metab Rep. 2018 Jul 20;16:57-63. doi: 10.1016/j.ymgmr.2018.06.006. eCollection 2018 Sep. Mol Genet Metab Rep. 2018. PMID: 30094186 Free PMC article.
-
Characterization of glycan substrates accumulating in GM1 Gangliosidosis.Mol Genet Metab Rep. 2019 Nov 3;21:100524. doi: 10.1016/j.ymgmr.2019.100524. eCollection 2019 Dec. Mol Genet Metab Rep. 2019. PMID: 31720227 Free PMC article.
-
Morquio-B disease: Clinical and genetic characteristics of a distinct GLB1-related dysostosis multiplex.JIMD Rep. 2019 Nov 28;51(1):30-44. doi: 10.1002/jmd2.12065. eCollection 2020 Jan. JIMD Rep. 2019. PMID: 32071837 Free PMC article.
-
Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation.PLoS One. 2010 Nov 16;5(11):e14010. doi: 10.1371/journal.pone.0014010. PLoS One. 2010. PMID: 21103358 Free PMC article.
-
β-Galactosidosis in Patient with Intermediate GM1 and MBD Phenotype.JIMD Rep. 2013;7:77-9. doi: 10.1007/8904_2012_145. Epub 2012 Apr 22. JIMD Rep. 2013. PMID: 23430499 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous